Bristol-Myers Squibb Deal History & Licensing Activity

About Bristol-Myers Squibb Licensing & Deal Activity

Bristol-Myers Squibb is a large pharma company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 56 deals over the past three years, Bristol-Myers Squibb ranks among the most acquisitive companies tracked by Ambrosia Ventures.

Key therapeutic areas of focus for Bristol-Myers Squibb include Oncology (53 deals and trials), Solid Tumors (16 deals and trials), CNS Disorders (9 deals and trials), and Autoimmune (8 deals and trials). In terms of modality, Bristol-Myers Squibb has shown particular interest in bispecific antibodies, radiopharmaceuticals, car-t.

Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Bristol-Myers Squibb and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Bristol-Myers Squibb's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.